- 2013/05/08 Consolidated Financial Report - 2Q, FY2012(PDF:181.1 KB)
- 2013/03/27 MEDINET and MaxCyte announce publication of joint collaboration supporting delivery of enhanced potency immunotherapy technology for treatment of cancer(PDF:123.9 KB)
- 2013/03/25 Completion of Payment for Stock Acquisition Rights Issued through Third Party Allotment (Target Issue Program "TIP" under Issuer's Permission for Execution)(PDF:82.0 KB)
- 2013/03/07 Allocation of New Shares/ Issue of Share Acquisition Rights to a Third Party(Target Issue Program "TIP" under Issuer's Permission for Execution)(PDF:97.2 KB)
- 2013/02/05 Consolidated Financial Report - 1Q, FY2012(PDF:153.7 KB)
For the contribution to "Patient First", we deliver innovation and effective technologies in medical care.